Shona Hendry

Adequate tumour cellularity is essential for accurate PD-L1 immunohistochemistry assessment on cytology cell-block specimens

Shona Hendry, David J Byrne, Michael Christie, Daniel P Steinfort, Louis B Irving, Carrie-Anne Wagner, Timothy Ellwood, Wendy A Cooper, Stephen B Fox

Journal article  |  2020  |  Cytopathology

OBJECTIVES: PD-L1 immunohistochemistry (IHC) is an essential predictive biomarker for patients with non-small cell lung cancer (NS..

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.

Jan Hudeček, Leonie Voorwerk, Maartje van Seijen, Iris Nederlof, Michiel de Maaker, Jose van den Berg, Koen K van de Vijver, Karolina Sikorska, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O Nielsen, Sunil S Badve, Stefan Michiels, William Fraser Symmans, Christos Sotiriou, David L Rimm, Stephen M Hewitt, Carsten Denkert, Sibylle Loibl, et al.

Journal article  |  2020  |  npj Breast Cancer

Stromal tumor-infiltrating lymphocytes (sTILs) are a potential predictive biomarker for immunotherapy response in metastatic tripl..

The Role of FDG - PET in Retroperitoneal Sarcomas - A Multicenter Retrospective Study

S Subramaniam, J Callahan, M Bressel, M Hofman, C Mitchell, S Hendry, FL Vissers, B van der Hiel, D Patel, WJ van Houdt, W Tseng, DE Gyorki

Conference Proceedings  |  2019  |  ANNALS OF SURGICAL ONCOLOGY

Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre

Hayden A Snow, Tatiana X Hitchen, Jessica Head, Alan Herschtal, Susie Bae, Sarat Chander, Julie Chu, Shona Hendry, Samuel Y Ngan, Jayesh Desai, Peter FM Choong, Michael Henderson, David E Gyorki

Journal article  |  2018  |  ANZ Journal of Surgery

Response to Editorial: The PD-L1 Immunohistochemistry Biomarker: Two Steps Forward, One Step Back?

Shona Hendry, Wendy A Cooper, Stephen B Fox

Journal article  |  2018  |  Journal of Thoracic Oncology

Comparison of Four PD-L1 Immunohistochemical Assays in Lung Cancer

Shona Hendry, David J Byrne, Gavin M Wright, Richard J Young, Sue Sturrock, Wendy A Cooper, Stephen B Fox

Journal article  |  2018  |  Journal of Thoracic Oncology

Prognostic Significance of PD-L1( ) and CD8( ) Immune Cells in HPV Oropharyngeal Squamous Cell Carcinoma

Benjamin Solomon, Richard J Young, Mathias Bressel, Damien Urban, Shona Hendry, Alesha Thai, Christopher Angel, Afaf Haddad, Marcin Kowanetz, Tsien Fua, June Corry, Stephen Fox, Danny Rischin

Journal article  |  2018  |  Cancer Immunology Research

Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples

RA Soo, JSY Lim, BR Asuncion, Z Fazreen, MC Herrera, MFM Omar, NHD Phuong, JE Seet, B Amanuel, B Iacopetta, D Byrne, S Hendry, S Fox, R Soong

Journal article  |  2018  |  Oncotarget

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen van de Vijver, MV Estrada, Paula I Gonzalez-Ericsson, Melinda Sanders, Benjamin sss Solomon, Cinzia Solinas, Gert GGM Van den Eynden, Yves Allory, Matthias Preusser, Johannes Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, et al.

Journal article  |  2017  |  Advances In Anatomic Pathology

Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features

Shona Hendry, Jia-Min B Pang, David J Byrne, Sunil R Lakhani, Margaret C Cummings, Ian G Campbell, G Bruce Mann, Kylie L Gorringe, Stephen B Fox

Journal article  |  2017  |  Clinical Cancer Research